SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech firesales
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (3165)11/6/2014 10:02:10 AM
From: tuck  Read Replies (1) of 3661
 
Interesting, thanks. Do you also follow Epizyme (EZYM)? It's down 22% this morning, also after 3Q results out. I'm sure it has something to do with their clinical update, and ASH abstract. Regarding the latter, results looked decent, considering it's P1 data, and the AE profile looked pretty benign in a pretreated population. But it was also disclosed that two patients dropped out for drug-related reasons. I suspect that disconnect is behind the drop this morning.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News